{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:14:13Z","timestamp":1783638853599,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04391-7","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:00:25Z","timestamp":1779112825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA HMGA2-AS1 promotes postoperative recurrence in non-muscle-invasive bladder cancer by sponging miR-367-3p to activate YAP1"],"prefix":"10.1186","volume":"24","author":[{"given":"Yingjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Nai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"2","key":"4391_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/0118744710269842240825160247","volume":"18","author":"TS Lim","year":"2025","unstructured":"Lim TS, Rahman IA, Umar A, Hidzir NM, Arkill KP, Sharif R, et al. An analysis of the radiosensitiser applications in the biomedical field. Curr Radiopharm. 2025;18(2):81\u201399.","journal-title":"Curr Radiopharm"},{"key":"4391_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"4","key":"4391_CR3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2022","unstructured":"Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK, et al. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2022;10(4):1367\u2013401.","journal-title":"Genes Dis"},{"key":"4391_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/0115701646319572240805103747","volume":"21","author":"R Mustafin","year":"2024","unstructured":"Mustafin R. The relationship of transposable elements with non-coding RNAs in the emergence of human proteins and peptides. Curr Proteomics. 2024;21:140\u201361.","journal-title":"Curr Proteomics"},{"key":"4391_CR5","doi-asserted-by":"publisher","first-page":"04109","DOI":"10.7189\/jogh.13.04109","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Rumgay H, Li M, Yu H, Pan H, Ni J. The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Glob Health. 2023;13:04109.","journal-title":"J Glob Health"},{"issue":"3 Pt B","key":"4391_CR6","first-page":"E78","volume":"111","author":"DA Green","year":"2012","unstructured":"Green DA, Rink M, Cha EK, Xylinas E, Chughtai B, Scherr DS, et al. Cost-effective treatment of low-risk carcinoma not invading bladder muscle. BJU Int. 2012;111(3 Pt B):E78\u201384.","journal-title":"BJU Int"},{"key":"4391_CR7","doi-asserted-by":"crossref","unstructured":"Wang C, Jiang H. Vitexin induces apoptosis and ferroptosis and suppresses malignant proliferation and invasion of bladder urothelial carcinoma through PI3K\/AKT-Nrf2 Axis. Lett Drug Des Discovery. 2024;21(11):2135\u201347.","DOI":"10.2174\/1570180820666230516160527"},{"issue":"7","key":"4391_CR8","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1364\/BOE.10.003533","volume":"10","author":"S Chen","year":"2019","unstructured":"Chen S, Zhu S, Cui X, Xu W, Kong C, Zhang Z, et al. Identifying non-muscle-invasive and muscle-invasive bladder cancer based on blood serum surface-enhanced Raman spectroscopy. Biomed Opt Express. 2019;10(7):3533\u201344.","journal-title":"Biomed Opt Express"},{"issue":"4","key":"4391_CR9","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.3390\/curroncol31040163","volume":"31","author":"D Parrao","year":"2024","unstructured":"Parrao D, Lizana N, Saavedra C, Larra\u00f1aga M, Lindsay CB, San Francisco IF, et al. Active surveillance in non-muscle invasive bladder cancer, the potential role of biomarkers: a systematic review. Curr Oncol. 2024;31(4):2201\u201320.","journal-title":"Curr Oncol"},{"issue":"5","key":"4391_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","volume":"19","author":"JY-C Teoh","year":"2022","unstructured":"Teoh JY-C, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M. Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. Nat Rev Urol. 2022;19(5):280\u201394.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"4391_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s40487-025-00375-x","volume":"13","author":"I Griebsch","year":"2025","unstructured":"Griebsch I, Shrestha S, Lotan Y, Ng C-F, Bottomley A. The impact of intravesical instillations on quality of life in patients with non-muscle-invasive bladder cancer: a systematic review. Oncol Ther. 2025;13(4):895\u2013918.","journal-title":"Oncol Ther"},{"key":"4391_CR12","doi-asserted-by":"crossref","unstructured":"Zhang X, Wang W, Zhu W, Dong J, Cheng Y, Yin Z et al. Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. Int J Mol Sci. 2019;20(22):5573.","DOI":"10.3390\/ijms20225573"},{"key":"4391_CR13","doi-asserted-by":"publisher","first-page":"1164301","DOI":"10.3389\/fcell.2023.1164301","volume":"11","author":"SK Baba","year":"2023","unstructured":"Baba SK, Baba SK, Mir R, Elfaki I, Algehainy N, Ullah MF, et al. Long non-coding RNAs modulate tumor microenvironment to promote metastasis: novel avenue for therapeutic intervention. Front Cell Dev Biol. 2023;11:1164301.","journal-title":"Front Cell Dev Biol"},{"key":"4391_CR14","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3389\/fonc.2019.01526","volume":"9","author":"G Ros","year":"2020","unstructured":"Ros G, Pegoraro S, De Angelis P, Sgarra R, Zucchelli S, Gustincich S, et al. HMGA2 antisense long non-coding RNAs as new players in the regulation of HMGA2 expression and pancreatic cancer promotion. Front Oncol. 2020;9:1526.","journal-title":"Front Oncol"},{"issue":"42","key":"4391_CR15","doi-asserted-by":"publisher","first-page":"e31075","DOI":"10.1097\/MD.0000000000031075","volume":"101","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Dai X, Lyu J, Li Y, Bao X, Deng F, et al. Construction and validation of a novel prognostic model for thyroid cancer based on N7-methylguanosine modification-related lncRNAs. Med (Baltim). 2022;101(42):e31075.","journal-title":"Med (Baltim)"},{"issue":"8","key":"4391_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/10815589251346948","volume":"73","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Zhang X, Liao H, Ye W. HMGA2-AS1 promotes the growth and cisplatin resistance in esophageal squamous cell carcinoma by enhancing HMGA2-dependent transcription of Snail2. J Investig Med. 2025;73(8):623\u201333.","journal-title":"J Investig Med"},{"key":"4391_CR17","doi-asserted-by":"publisher","first-page":"1036098","DOI":"10.3389\/fgene.2022.1036098","volume":"13","author":"K Jiang","year":"2022","unstructured":"Jiang K, Wu L, Yin X, Tang Q, Yin J, Zhou Z, et al. Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer. Front Genet. 2022;13:1036098.","journal-title":"Front Genet"},{"issue":"11","key":"4391_CR18","doi-asserted-by":"publisher","first-page":"e32018","DOI":"10.1016\/j.heliyon.2024.e32018","volume":"10","author":"Z Yang","year":"2024","unstructured":"Yang Z, Li X, Zhou L, Luo Y, Zhan N, Ye Y, et al. Ferroptosis-related lncRNAs: Distinguishing heterogeneity of the tumour microenvironment and predicting immunotherapy response in bladder cancer. Heliyon. 2024;10(11):e32018.","journal-title":"Heliyon"},{"key":"4391_CR19","doi-asserted-by":"publisher","first-page":"114672","DOI":"10.1016\/j.biopha.2023.114672","volume":"162","author":"B Ma","year":"2023","unstructured":"Ma B, Wang S, Wu W, Shan P, Chen Y, Meng J, et al. Mechanisms of circRNA\/lncRNA-miRNA interactions and applications in disease and drug research. Biomed Pharmacother. 2023;162:114672.","journal-title":"Biomed Pharmacother"},{"issue":"20","key":"4391_CR20","doi-asserted-by":"publisher","first-page":"17807","DOI":"10.1007\/s00432-023-05484-6","volume":"149","author":"X Wei","year":"2023","unstructured":"Wei X, Jiang Y, Yang G, Chang T, Sun G, Chen S, et al. MicroRNA-367-3p directly targets RAB23 and inhibits proliferation, migration and invasion of bladder cancer cells and increases cisplatin sensitivity. J Cancer Res Clin Oncol. 2023;149(20):17807\u201321.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4391_CR21","doi-asserted-by":"publisher","first-page":"102065","DOI":"10.1016\/j.tranon.2024.102065","volume":"48","author":"X Zhou","year":"2024","unstructured":"Zhou X, Xiao L, Meng F, Zuo F, Wu W, Li G, et al. GAS6-AS1 drives bladder cancer progression by increasing MMP7 expression in a ceRNA- and RBP-dependent manner. Transl Oncol. 2024;48:102065.","journal-title":"Transl Oncol"},{"issue":"1","key":"4391_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41389-023-00489-9","volume":"12","author":"B Doshi","year":"2023","unstructured":"Doshi B, Athans SR, Woloszynska A. Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions. Oncogenesis. 2023;12(1):44.","journal-title":"Oncogenesis"},{"key":"4391_CR23","doi-asserted-by":"crossref","unstructured":"Abugomaa A, Elbadawy M, Yamawaki H, Usui T, Sasaki K. Emerging roles of cancer stem cells in bladder cancer progression, tumorigenesis, and resistance to chemotherapy: a potential therapeutic target for bladder cancer. Cells. 2020;9(1):235.","DOI":"10.3390\/cells9010235"},{"key":"4391_CR24","doi-asserted-by":"crossref","unstructured":"Patwardhan MV, Mahendran R. The bladder tumor microenvironment components that modulate the tumor and impact therapy. Int J Mol Sci. 2023;24(15):12311.","DOI":"10.3390\/ijms241512311"},{"key":"4391_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2490-14-5","volume":"14","author":"H Kobayashi","year":"2014","unstructured":"Kobayashi H, Kikuchi E, Mikami S, Maeda T, Tanaka N, Miyajima A, et al. Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression. BMC Urol. 2014;14:5.","journal-title":"BMC Urol"},{"key":"4391_CR26","doi-asserted-by":"publisher","first-page":"704902","DOI":"10.3389\/fsurg.2021.704902","volume":"8","author":"AD Asimakopoulos","year":"2021","unstructured":"Asimakopoulos AD, Colalillo G, Telesca R, Mauriello A, Miano R, Di Stasi SM, et al. T1 Bladder cancer: comparison of the prognostic impact of two substaging systems on disease recurrence and progression and suggestion of a novel nomogram. Front Surg. 2021;8:704902.","journal-title":"Front Surg"},{"key":"4391_CR27","doi-asserted-by":"crossref","unstructured":"Shabbir R, Quiles CG, Lane B, Zeef L, Hoskin PJ, Choudhury A et al. Gene expression in muscle-invasive and non-muscle-invasive bladder cancer cells exposed to hypoxia. Cancers (Basel). 2025;17(16):2624.","DOI":"10.3390\/cancers17162624"},{"key":"4391_CR28","doi-asserted-by":"publisher","first-page":"156301","DOI":"10.1016\/j.prp.2025.156301","volume":"278","author":"H Cui","year":"2025","unstructured":"Cui H, Fan X. Targeting the NR4A3-RNF139-ATF6 pathway as a therapeutic and diagnostic strategy in bladder cancer. Pathol Res Pract. 2025;278:156301.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"4391_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41392-024-01955-5","volume":"9","author":"Z Liu","year":"2024","unstructured":"Liu Z, Chen J, Ren Y, Liu S, Ba Y, Zuo A, et al. Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Signal Transduct Target Ther. 2024;9(1):270.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"4391_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/kjm2.12798","volume":"40","author":"P-I Liang","year":"2024","unstructured":"Liang P-I, Wei Y-C, Chen H-D, Ma Y-C, Ke H-L, Chien C-C, et al. TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma. Kaohsiung J Med Sci. 2024;40(3):269\u201379.","journal-title":"Kaohsiung J Med Sci"},{"issue":"1","key":"4391_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","volume":"10","author":"H Lee","year":"2025","unstructured":"Lee H, Kim B, Park J, Park S, Yoo G, Yum S, et al. Cancer stem cells: landscape, challenges and emerging therapeutic innovations. Signal Transduct Target Ther. 2025;10(1):248.","journal-title":"Signal Transduct Target Ther"},{"key":"4391_CR32","doi-asserted-by":"crossref","unstructured":"Loh C-Y, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK et al. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: signaling, therapeutic implications, and challenges. Cells. 2019;8(10):1118.","DOI":"10.3390\/cells8101118"},{"key":"4391_CR33","doi-asserted-by":"crossref","unstructured":"Du W, Li D, Xie J, Tang P. miR\u2013367\u20133p downregulates Rab23 expression and inhibits Hedgehog signaling resulting in the inhibition of the proliferation, migration, and invasion of prostate cancer cells. Oncol Rep. 2021;46(3):192.","DOI":"10.3892\/or.2021.8143"},{"key":"4391_CR34","doi-asserted-by":"crossref","unstructured":"Yang X, Qu Y, Zhang J. Up-Regulated LncRNA FEZF1-AS1 promotes the progression of cervical carcinoma cells via MiR-367-3p\/SLC12A5 Signal Axis. Arch Med Res. 2021;53(1):9\u201319.","DOI":"10.1016\/j.arcmed.2021.05.004"},{"key":"4391_CR35","doi-asserted-by":"crossref","unstructured":"Liang M, Liu Z, Lin H, Shi B, Li M, Chen T et al. High-throughput sequencing reveals circular RNA hsa_circ_0000592 as a novel player in the carcinogenesis of gastric carcinoma. Biosci Rep. 2019;39(6):BSR20181900.","DOI":"10.1042\/BSR20181900"},{"issue":"5","key":"4391_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","volume":"5","author":"CDK Nguyen","year":"2019","unstructured":"Nguyen CDK, Yi C. YAP\/TAZ signaling and resistance to cancer therapy. Trends Cancer. 2019;5(5):283\u201396.","journal-title":"Trends Cancer"},{"issue":"11","key":"4391_CR37","doi-asserted-by":"publisher","first-page":"12581","DOI":"10.1002\/cam4.5932","volume":"12","author":"C Zhang","year":"2023","unstructured":"Zhang C, Wang M, Ying Y, Meng F, Gao H, Zeng S, et al. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells. Cancer Med. 2023;12(11):12581\u201392.","journal-title":"Cancer Med"},{"key":"4391_CR38","doi-asserted-by":"crossref","unstructured":"Sadhukhan P, Feng M, Illingworth E, Sloma I, Ooki A, Matoso A et al. YAP1 induces bladder cancer progression and promotes immune evasion through IL-6\/STAT3 pathway and CXCL deregulation. J Clin Invest. 2024;135(2):e171164.","DOI":"10.1172\/JCI171164"},{"issue":"8","key":"4391_CR39","doi-asserted-by":"publisher","first-page":"e1005465","DOI":"10.1371\/journal.pgen.1005465","volume":"11","author":"C Stein","year":"2015","unstructured":"Stein C, Bardet AF, Roma G, Bergling S, Clay I, Ruchti A, et al. YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers. PLoS Genet. 2015;11(8):e1005465.","journal-title":"PLoS Genet"},{"key":"4391_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cancergen.2025.03.006","volume":"294\u2013295","author":"T Kiba","year":"2025","unstructured":"Kiba T. Mutation status in yes-associated protein 1 (YAP1) in an insulinoma cell line Rin-5F. Cancer Genet. 2025;294\u2013295:76\u20139.","journal-title":"Cancer Genet"},{"issue":"1","key":"4391_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/jca.100922","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu H, Li Y, Karsidag M, Tu T, Wang P. Technical and biological biases in bulk transcriptomic data mining for cancer research. J Cancer. 2025;16(1):34\u201343.","journal-title":"J Cancer"},{"issue":"12","key":"4391_CR42","doi-asserted-by":"publisher","first-page":"102042","DOI":"10.1016\/j.genrep.2024.102042","volume":"37","author":"H Liu","year":"2024","unstructured":"Liu H, Guo Z, Wang P. Genetic expression in cancer research: challenges and complexity. Gene Rep. 2024;37(12):102042.","journal-title":"Gene Rep"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04391-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:28:22Z","timestamp":1783636102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04391-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4391"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04391-7","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that they have obtained Tongxiang First People\u2019s Hospital review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"285"}}